Description
Glycomix™ strong anion-exchange phase is made of narrow-dispersed and hydrophilic polymer particles. It is a strong anion exchanger with quaternary ammonium functional groups that are chemically bonded to the hydrophilic surface of the polymer particles.
Packing
Chemical composition of Glycomix™ SAX
Glycomix™ SAX Technical Specifications
Characteristics |
Glycomix™ SAX |
Functional Group |
Quaternary ammonium |
Surface characteristics |
Hydrophilic |
pH range |
2 - 12 |
Typical backpressure for 4.6×250 mm |
10 bar for 0.22 mL/min
38 bar for 1 mL/min |
Maximum backpressure |
~ 1,500 (psi) |
Salt concentration range |
20 mM - 2.0 M |
Maximum temperature |
~ 80 (°C) |
Mobile phase compatibility |
Aqueous and organic |
Applications |
Heparin, highly charged polysaccharides |
Characteristic
Featured Characteristics
- High capacity and high resolution
- High lot-to-lot reproducibility
- Wide pH range (2-12)
- From analytical to preparative scale
- Ideal for separation and analysis of heparin, glycans
High Lot to lot Reproducibility
With well-controlled surface chemistry and resin production, Glycomix resins exhibit high lot to lot reproducibility which leads to consistent column performance. The separation variation for Heparin from batch to batch is less than 1% for retention time and 5% for the peak area.
Figure 2. High Lot-to-lot reproducibility of three lots of Glycomix™ SAX resins.
Conditions |
|
Column: |
Glycomix™ SAX, 4.6×250mm |
Mobile phase: |
A: 0.04% NaH2PO4, pH 3.0
B: 0.04% NaH2PO4+14% NaClO4, pH 3.0 |
Flow rate: |
0.22 mL/min |
Gradient: |
20% - 90% B in 60 minutes |
Wavelength: |
202 nm |
Temperature: |
25 °C |
Injection volume: |
10 µL |
Pressure: |
9.5 bar |
Sample: |
20 mg/mL Heparin sodium
1 mg/mL Dermatan sulfate (DS)
1 mg/mL Oversulfated chondroitin sulfate (OSCS) in H2O |
Lot-to-Lot peak retention time relative standard deviation.
Peak Name |
Lot A |
Lot B |
Lot C |
RSD% |
Chondroitin Sulfate B |
12.286 |
12.300 |
12.434 |
0.41% |
Heparin |
21.71 |
21.723 |
21.919 |
0.44% |
OSCS |
33.936 |
33.853 |
34.114 |
0.32% |
Long column life time
Glycomix™ SAX has long column life time due to its resin surface chemistry and stable manufacturing process. Figure below exhibits one column's performance for duplicated injections. The column shows consistent separation efficiency.
Figure 3. Chromatogram overlays of duplicated injections.
Conditions |
|
Column: |
Glycomix™ SAX, 4.6×250mm |
Guard Column: |
Glycomix™ SAX, 4.6×50mm |
Mobile phase: |
A: 0.04% NaH2PO4, pH 3.0
B: 0.04% NaH2PO4+14% NaClO4, pH 3.0 |
Flow rate: |
0.22 mL/min |
Gradient: |
20% - 90% B in 60 minutes |
Wavelength: |
202 nm |
Temperature: |
25 °C |
Injection volume: |
10 µL |
Pressure: |
9.5 bar |
Sample: |
20 mg/mL Heparin sodium
1 mg/mL Dermatan sulfate (DS)
1 mg/mL Oversulfated chondroitin sulfate (OSCS) in H2O |
Sensitive separation of different Heparin loading
Glycomix™ SAX is able to separate components from commercially available standards. In Figure 4, Panel A shows the standard run with 20mg/mL Heparin, 1mg/mL DS and 1 mg/mL OSCS. Panel B is the OSCS chromatogram with 1 mg/mL concentration. In comparison to Panel B, the small peak between DS and Heparin comes from the standard OSCS sample. Column running conditions are the same as for Figure 3.
Glycomix™ SAX can be used in the quantitative analysis of Heparin and its impurities. Figure 5 shows the different heparin loadings over concentration range from 0.5 mg/ml to 10 mg/ml, 0.125 mg/ml to 4 mg/ml for OSCS and 0.25 mg/ml to 4 mg/ml for DS. The R2 values for both standards exceed 0.99 in the tested concentration range.
Figure 4. Chromatogram overlays of OSCS standard and Heparin with DS and OSCS.
Figure 5. Chromatogram overlays of different heparin injections from 0.5mg/mL to 10mg/mL concentration, DS from 0.125 mg/mL to 4.0 mg/mL and OSCS from 0.25 mg/mL to 4.0 mg/mL.
Conditions |
|
Column: |
Glycomix™ SAX, 4.6×250mm |
Guard Column: |
Glycomix™ SAX, 4.6×50mm |
Mobile phase: |
A: 0.04% NaH2PO4, pH 3.0
B: 0.04% NaH2PO4+14% NaClO4, pH 3.0 |
Flow rate: |
0.22 mL/min |
Gradient: |
20% - 90% B in 60 minutes |
Wavelength: |
202 nm |
Temperature: |
25 °C |
Injection volume: |
10 µL |
Pressure: |
9.5 bar |
Sample: |
20 mg/mL Heparin sodium
1 mg/mL Dermatan sulfate (DS)
1 mg/mL Oversulfated chondroitin sulfate (OSCS) in H2O |
Column Performance Comparison
In comparison, Glycomix™ SAX performs superior to Dionex's column for heparin separation.1,2 Figure 7 shows the chromatogram of Heparin separation from Glycomix™ SAX. The resolutions are 3.8 between DS and heparin, 5.8 between heparin and OSCS. The U.S. Pharmacopeia (USP) requirements for the separation for DS/ heparin are 1.0 and 1.5 for OSCS /heparin3. GlycomixTM SAX has a much better separation resolution than USP's requirement. In Dionex's application note, Dionex IonPac AG11 guard with AS11 analytical column gives a 1.1 and 1.8 resolution for DS/heparin and heparin/OSCS respectively.
Figure 7. Heparin Sodium, Chondriotin Sulfate B, and Oversulfated Chondroitin Sulfate separation on Glycomix™ SAX.
Conditions |
|
Column: |
Glycomix™ SAX, 4.6×250mm |
Guard Column: |
Glycomix™ SAX, 4.6×50mm |
Mobile phase: |
A: 0.04% NaH2PO4, pH 3.0
B: 0.04% NaH2PO4+14% NaClO4, pH 3.0 |
Flow rate: |
0.22 mL/min |
Gradient: |
20% - 90% B in 60 minutes |
Wavelength: |
202 nm |
Temperature: |
25 °C |
Injection volume: |
10 µL |
Pressure: |
10 bar |
Sample: |
20 mg/mL Heparin Sodium
0.2 mg/mL Dermatan Sulfate (DS)
0.2 mg/mL Oversulfated Chondroitin Sulfate (OSCS) |
bio-equip.cn
Profile
Sepax Technologies, Inc., a privately held company, was founded in Delaware, USA in November 2002. It develops and manufactures HPLC consumables, bulk media, and equipment in liquid chromatography for chemical and biological separations. It is a fast growing technology company and owns patents, proprietary technologies and know-how. Sepax has emerged as a leader in the biological separation industry in the global market.
Business strategies
Sepax Technologies, Inc. develops innovative HPLC consumables, bulk media, and instruments to solve separation challenges in the global market. We provide solution-based products by closely working with our customer scientists in pharmaceuticals, biopharmaceuticals, research institutes and government labs. Our strong technical team develops various methods with our customers to analyze complex biological molecules. As a leader in the biological separation industry, we constantly develop the best bio-separation technologies and products for our global customers. We have reached a competitive position globally in fast growing regions.
Vision Statement
To become a technology leader in the biological separation industry in the global market and provide solution based products and services for our customers.
Operation
Sepax Technologies, Inc.
Our company headquarter in Delaware is located in Delaware Technology Park with facilities of 15,000 ft2 dedicated to the development of separation resin technologies and instrumentation, production of HPLC resins, columns and CE consumables. It is also the marketing and sales center for our US and global markets.
Sales
Domestic
Audrey Fisher
Field Sales Account Manager
(Northern CA areas, UT, CO, OR)
Direct Phone: 925-324-5223
Email: afisher@sepax-tech.com
Kathleen Falls
West Coast Regional Manager
(All other CA areas, WA, TX, AZ, NM, MI)
Direct Phone: 323-228-0004
Email: kfalls@sepax-tech.com
Michael Hunnewell
Field Sales Account Manager
(MA, RI, NH, CT, NY)
Direct Phone: 302-650-3955
Email: mhunnewell@sepax-tech.com
Colleen Callahan
Midwest Account Manager
(WI, IL, IN, OH, MO)
Direct Phone: 302-366-1101, ext 106
Cell Phone: 302-339-8747
Email: ccallahan@sepax-tech.com
All other areas, please contact
Helen Gu
Vice President, Sales
Direct phone: 302-650-3909
Email: hgu@sepax-tech.com
International
Tingting Wu
Executive Account Manager/Marketing
Phone: 302-366-1101, ext 115
Email: twu@sepax-tech.com